Solid Biosciences Inc Kurs/ Buchwert
Was ist das Kurs/ Buchwert von Solid Biosciences Inc?
Kurs/ Buchwert von Solid Biosciences Inc ist 5.72
Was ist die Definition von Kurs/ Buchwert?
Kurs-Buchwert-Verhältnis repräsentiert das Verhältnis zwischen dem Aktienwert eines Unternehmens und dem Buchwert pro Aktie.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Kurs/ Buchwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Solid Biosciences Inc
Was macht Solid Biosciences Inc?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Unternehmen mit kurs/ buchwert ähnlich Solid Biosciences Inc
- Biocon hat Kurs/ Buchwert von 5.71
- Miragen Therapeutics Inc hat Kurs/ Buchwert von 5.71
- Aeeris hat Kurs/ Buchwert von 5.71
- AusNet Services Ltd hat Kurs/ Buchwert von 5.71
- Teradyne hat Kurs/ Buchwert von 5.71
- NIO Inc hat Kurs/ Buchwert von 5.71
- Solid Biosciences Inc hat Kurs/ Buchwert von 5.72
- Adaptimmune Therapeutics Plc hat Kurs/ Buchwert von 5.72
- STADA Arzneimittel Aktiengesellschaft hat Kurs/ Buchwert von 5.72
- Amlogic (Shanghai) Co hat Kurs/ Buchwert von 5.72
- La Forestiere Equatoriale SA hat Kurs/ Buchwert von 5.72
- Palred Technologies hat Kurs/ Buchwert von 5.72
- The Hi-Tech Gears hat Kurs/ Buchwert von 5.73